Annual CFF:
$364.91M+$343.71M(+1621.34%)Summary
- As of today, CNTA annual cash from financing is $364.91 million, with the most recent change of +$343.71 million (+1621.34%) on December 31, 2024.
- During the last 3 years, CNTA annual cash from financing has fallen by -$295.16 million (-44.72%).
- CNTA annual cash from financing is now -44.72% below its all-time high of $660.07 million, reached on December 31, 2021.
Performance
CNTA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$1.63M-$1.46M(-47.27%)Summary
- As of today, CNTA quarterly cash from financing is $1.63 million, with the most recent change of -$1.46 million (-47.27%) on June 1, 2025.
- Over the past year, CNTA quarterly cash from financing has dropped by -$103.72 million (-98.45%).
- CNTA quarterly cash from financing is now -99.53% below its all-time high of $345.41 million, reached on June 30, 2021.
Performance
CNTA Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$253.79M-$103.72M(-29.01%)Summary
- As of today, CNTA TTM cash from financing is $253.79 million, with the most recent change of -$103.72 million (-29.01%) on June 1, 2025.
- Over the past year, CNTA TTM cash from financing has increased by +$116.77 million (+85.21%).
- CNTA TTM cash from financing is now -61.55% below its all-time high of $660.07 million, reached on December 31, 2021.
Performance
CNTA TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CNTA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +1621.3% | -98.5% | +85.2% |
| 3Y3 Years | -44.7% | +2250.4% | +250.9% |
| 5Y5 Years | +3952.3% | - | - |
CNTA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -44.7% | >+9999.0% | -99.3% | +1085.2% | -31.4% | >+9999.0% |
| 5Y | 5-Year | -44.7% | >+9999.0% | -99.5% | +252.4% | -61.5% | >+9999.0% |
| All-Time | All-Time | -44.7% | >+9999.0% | -99.5% | +252.4% | -61.5% | >+9999.0% |
CNTA Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.63M(-47.3%) | $253.79M(-29.0%) |
| Mar 2025 | - | $3.10M(+107.9%) | $357.52M(-2.0%) |
| Dec 2024 | $364.91M(+1621.3%) | $1.49M(-99.4%) | $364.91M(-1.3%) |
| Sep 2024 | - | $247.57M(+135.0%) | $369.79M(+169.9%) |
| Jun 2024 | - | $105.36M(+904.6%) | $137.03M(+332.5%) |
| Mar 2024 | - | $10.49M(+64.4%) | $31.69M(+49.5%) |
| Dec 2023 | $21.20M(+4541.8%) | $6.38M(-56.9%) | $21.20M(+44.6%) |
| Sep 2023 | - | $14.81M(>+9900.0%) | $14.66M(>+9900.0%) |
| Jun 2023 | - | $12.10K(>+9900.0%) | $66.30K(-46.4%) |
| Mar 2023 | - | $0.00(+100.0%) | $123.70K(-72.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $456.70K(-99.9%) | -$165.80K(-175.4%) | $456.80K(-99.4%) |
| Sep 2022 | - | $220.00K(+216.5%) | $73.62M(+1.8%) |
| Jun 2022 | - | $69.50K(-79.1%) | $72.33M(-82.7%) |
| Mar 2022 | - | $333.10K(-99.5%) | $417.67M(-36.7%) |
| Dec 2021 | $660.07M(>+9900.0%) | $73.00M(+6909.1%) | $660.07M(+12.4%) |
| Sep 2021 | - | -$1.07M(-100.3%) | $587.07M(-0.2%) |
| Jun 2021 | - | $345.41M(+42.3%) | $588.14M(+142.3%) |
| Mar 2021 | - | $242.73M | $242.73M |
| Dec 2020 | $5.05M(-43.9%) | - | - |
| Dec 2019 | $9.01M | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual cash from financing?
- What is the all-time high annual cash from financing for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual cash from financing year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly cash from financing year-on-year change?
- What is Centessa Pharmaceuticals plc TTM cash from financing?
- What is the all-time high TTM cash from financing for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM cash from financing year-on-year change?
What is Centessa Pharmaceuticals plc annual cash from financing?
The current annual cash from financing of CNTA is $364.91M
What is the all-time high annual cash from financing for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual cash from financing is $660.07M
What is Centessa Pharmaceuticals plc annual cash from financing year-on-year change?
Over the past year, CNTA annual cash from financing has changed by +$343.71M (+1621.34%)
What is Centessa Pharmaceuticals plc quarterly cash from financing?
The current quarterly cash from financing of CNTA is $1.63M
What is the all-time high quarterly cash from financing for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly cash from financing is $345.41M
What is Centessa Pharmaceuticals plc quarterly cash from financing year-on-year change?
Over the past year, CNTA quarterly cash from financing has changed by -$103.72M (-98.45%)
What is Centessa Pharmaceuticals plc TTM cash from financing?
The current TTM cash from financing of CNTA is $253.79M
What is the all-time high TTM cash from financing for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM cash from financing is $660.07M
What is Centessa Pharmaceuticals plc TTM cash from financing year-on-year change?
Over the past year, CNTA TTM cash from financing has changed by +$116.77M (+85.21%)